Rheumatology International

, Volume 35, Issue 6, pp 1053–1058 | Cite as

Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience

  • Lorna Stemberger MaricEmail author
  • Ivica Knezovic
  • Neven Papic
  • Branko Mise
  • Srdan Roglic
  • Leo Markovinovic
  • Goran Tesovic
Short Communication - Observational Research


Kawasaki disease (KD) is an acute systemic vasculitis of childhood. Due to development of coronary artery aneurysms (CAA) it is considered the most common cause of acquired heart disease in children. The clinical and laboratory features of patients with complete and incomplete KD were compared in order to identify the possible predictors of CAA development. A cross-sectional study of children with KD treated at the University Hospital for Infectious Diseases, Zagreb, between January 2003 and December 2012 was conducted. A total of 111 KD patients were included; 70.3 % patients had complete KD. Patients with complete KD had more frequently rash, changes on extremities and mucous membranes, as well as higher serum bilirubin, aminotransferases, gamma-glutamyl transferase and lactate dehydrogenase levels. Patients with incomplete KD had longer duration of fever before the diagnosis (8 vs. 7 days) and delayed IVIG treatment (day 8 vs. 7). CAA was detected in seven children (6.3 %). Disease duration before hospitalization >6 days (OR 7.16, 95 % CI 1.51–100.35), age <6 months (OR 25.86, 95 % CI 1.68–398.35) and platelet count >771 after the 7th day of disease (OR 13.33, 95 % CI 2.19–80.87) were independently associated with CAA development. The diagnosis and treatment in incomplete KD can be delayed due to the absence of major criteria. Age, duration of symptoms prior hospitalization and platelet count were identified as independent predictors of CAA development.


Kawasaki disease Incomplete Kawasaki disease Coronary artery aneurysm CAA IVIG 



The authors thank Mrs. Arijana Pavelić for her help in the preparation of the manuscript.

Conflict of interest

All the authors hereby declare that they have no conflicts of interest.


  1. 1.
    Freeman AF, Shulman ST (2006) Kawasaki disease: summary of the American Heart Association guidelines. Am Fam Physician 74(7):1141–1148PubMedGoogle Scholar
  2. 2.
    Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R (1996) Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94(6):1379–1385CrossRefPubMedGoogle Scholar
  3. 3.
    Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA, Committee on Rheumatic Fever E, Kawasaki Disease CoCDitYAHA (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young. American Heart Association. Pediatrics 114(6):1708–1733. doi: 10.1542/peds.2004-2182 Google Scholar
  4. 4.
    Giannouli G, Tzoumaka-Bakoula C, Kopsidas I, Papadogeorgou P, Chrousos GP, Michos A (2013) Epidemiology and risk factors for coronary artery abnormalities in children with complete and incomplete Kawasaki disease during a 10-year period. Pediatr Cardiol 34(6):1476–1481. doi: 10.1007/s00246-013-0673-9 CrossRefPubMedGoogle Scholar
  5. 5.
    Uehara R, Belay ED (2012) Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol 22(2):79–85CrossRefPubMedCentralPubMedGoogle Scholar
  6. 6.
    Salo E, Griffiths EP, Farstad T, Schiller B, Nakamura Y, Yashiro M, Uehara R, Best BM, Burns JC (2012) Incidence of Kawasaki disease in northern European countries. Pediatr Int 54(6):770–772. doi: 10.1111/j.1442-200X.2012.03692.x CrossRefPubMedCentralPubMedGoogle Scholar
  7. 7.
    Burns JC, Herzog L, Fabri O, Tremoulet AH, Rodo X, Uehara R, Burgner D, Bainto E, Pierce D, Tyree M, Cayan D, Kawasaki Disease Global Climate C (2013) Seasonality of Kawasaki disease: a global perspective. PloS One 8(9):e74529. doi: 10.1371/journal.pone.0074529 CrossRefPubMedCentralPubMedGoogle Scholar
  8. 8.
    Ghelani SJ, Sable C, Wiedermann BL, Spurney CF (2012) Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American Heart Association guidelines. Pediatr Cardiol 33(7):1097–1103. doi: 10.1007/s00246-012-0232-9 CrossRefPubMedGoogle Scholar
  9. 9.
    Gorczyca D, Postepski J, Olesinska E, Lubieniecka M, Lachor-Motyka I, Opoka-Winiarska V, Gruenpeter A (2014) The clinical profile of Kawasaki disease of children from three Polish centers: a retrospective study. Rheumatol Int 34(6):875–880. doi: 10.1007/s00296-013-2836-7 CrossRefPubMedCentralPubMedGoogle Scholar
  10. 10.
    Lin YT, Manlhiot C, Ching JC, Han RK, Nield LE, Dillenburg R, Pepelassis D, Lai LS, Smythe JF, Chahal N, Yeung RS, McCrindle BW (2010) Repeated systematic surveillance of Kawasaki disease in Ontario from 1995 to 2006. Pediatr Int 52(5):699–706. doi: 10.1111/j.1442-200X.2010.03092.x CrossRefPubMedGoogle Scholar
  11. 11.
    Kim GB, Han JW, Park YW, Song MS, Hong YM, Cha SH, Kim DS, Park S (2014) Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009–2011. Pediatr Infect Dis J 33(1):24–27. doi: 10.1097/INF.0000000000000010 CrossRefPubMedGoogle Scholar
  12. 12.
    Anderson MS, Todd JK, Glode MP (2005) Delayed diagnosis of Kawasaki syndrome: an analysis of the problem. Pediatrics 115(4):e428–e433. doi: 10.1542/peds.2004-1824 CrossRefPubMedGoogle Scholar
  13. 13.
    Kim T, Choi W, Woo CW, Choi B, Lee J, Lee K, Son C, Lee J (2007) Predictive risk factors for coronary artery abnormalities in Kawasaki disease. Eur J Pediatr 166(5):421–425. doi: 10.1007/s00431-006-0251-8 CrossRefPubMedGoogle Scholar
  14. 14.
    Manlhiot C, Christie E, McCrindle BW, Rosenberg H, Chahal N, Yeung RS (2012) Complete and incomplete Kawasaki disease: two sides of the same coin. Eur J Pediatr 171(4):657–662. doi: 10.1007/s00431-011-1631-2 CrossRefPubMedGoogle Scholar
  15. 15.
    Nakamura Y, Yashiro M, Uehara R, Watanabe M, Tajimi M, Oki I, Ojima T, Sonobe T, Yanagawa H (2004) Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease. Pediatr Int 46(1):33–38. doi: 10.1111/j.1442-200X.2004.01840.x CrossRefPubMedGoogle Scholar
  16. 16.
    Yellen ES, Gauvreau K, Takahashi M, Burns JC, Shulman S, Baker AL, Innocentini N, Zambetti C, Pancheri JM, Ostrow A, Frazer JR, Sundel RP, Fulton DR, Newburger JW (2010) Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease. Pediatrics 125(2):e234–e241. doi: 10.1542/peds.2009-0606 CrossRefPubMedCentralPubMedGoogle Scholar
  17. 17.
    Patel A, Holman RC, Callinan LS, Sreenivasan N, Schonberger LB, Fischer TK, Belay ED (2013) Evaluation of clinical characteristics of Kawasaki syndrome and risk factors for coronary artery abnormalities among children in Denmark. Acta Paediatr 102(4):385–390. doi: 10.1111/apa.12142 CrossRefPubMedGoogle Scholar
  18. 18.
    Son MB, Gauvreau K, Ma L, Baker AL, Sundel RP, Fulton DR, Newburger JW (2009) Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006. Pediatrics 124(1):1–8. doi: 10.1542/peds.2008-0730 CrossRefPubMedGoogle Scholar
  19. 19.
    Tacke CE, Breunis WB, Pereira RR, Breur JM, Kuipers IM, Kuijpers TW (2014) Five years of Kawasaki disease in the Netherlands: a national surveillance study. Pediatr Infect Dis J 33(8):793–797. doi: 10.1097/INF.0000000000000271 CrossRefPubMedGoogle Scholar
  20. 20.
    Weng KP, Hsieh KS, Huang SH, Ou SF, Ma CY, Ho TY, Lai CR, Ger LP (2012) Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease. Kaohsiung J Med Sci 28(1):23–29. doi: 10.1016/j.kjms.2011.09.002 CrossRefPubMedGoogle Scholar
  21. 21.
    Chen J, Liu Y, Liu W, Wu Z (2011) A meta-analysis of the biomarkers associated with coronary artery lesions secondary to Kawasaki disease in Chinese children. J Huazhong Univ Sci Technol Med Sci 31(5):705–711. doi: 10.1007/s11596-011-0587-9 CrossRefPubMedGoogle Scholar
  22. 22.
    Ishiguro A, Ishikita T, Shimbo T, Matsubara K, Baba K, Hayashi Y, Naritaka S, Nakahata T (1998) Elevation of serum thrombopoietin precedes thrombocytosis in Kawasaki disease. Thromb Haemost 79(6):1096–1100PubMedGoogle Scholar
  23. 23.
    Chang FY, Hwang B, Chen SJ, Lee PC, Meng CC, Lu JH (2006) Characteristics of Kawasaki disease in infants younger than six months of age. Pediatr Infect Dis J 25(3):241–244. doi: 10.1097/01.inf.0000202067.50975.90 CrossRefPubMedGoogle Scholar
  24. 24.
    Song D, Yeo Y, Ha K, Jang G, Lee J, Lee K, Son C, Lee J (2009) Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age. Eur J Pediatr 168(11):1315–1321. doi: 10.1007/s00431-009-0925-0 CrossRefPubMedGoogle Scholar
  25. 25.
    Ha KS, Jang G, Lee J, Lee K, Hong Y, Son C, Lee J (2013) Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis. Eur J Pediatr 172(3):343–349. doi: 10.1007/s00431-012-1891-5 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Lorna Stemberger Maric
    • 1
    Email author
  • Ivica Knezovic
    • 1
  • Neven Papic
    • 2
  • Branko Mise
    • 1
    • 3
  • Srdan Roglic
    • 1
  • Leo Markovinovic
    • 1
  • Goran Tesovic
    • 1
    • 3
  1. 1.Clinical Department for Pediatric Infectious DiseasesUniversity Hospital for Infectious ZagrebZagrebCroatia
  2. 2.Department for Viral Hepatitis, ZagrebUniversity Hospital for Infectious DiseasesZagrebCroatia
  3. 3.School of MedicineUnversity of ZagrebZagrebCroatia

Personalised recommendations